研究方向：缩氨基硫脲类抗肿瘤金属化合物的研究

在读期间发表论文：

1. Qi JX, Gou Y, Zhang Y, Yang K, Chen SF, Liu L, Wu XY, Wang T*, Zhang W*, Yang F*. Developing anticancer ferric prodrugs based on the N-donor residues of human serum albumin carrier IIA subdomain. Journal of Medicinal Chemistry, 2016, 59: 7497−7511.

2. Qi JX, Zhang Y, Gou Y, Zhang ZL, Zhou ZP, Wu XY, Yang F*, Liang H*. Developing an anticancer copper(II) pro-drug based on the His242 residue of the human serum albumin carrier IIA subdomain. Molecular Pharmaceutics, 2016, 13: 1501−1507. 

3. Qi JX, Zhang Y, Gou Y, Lee P, Wang J, Chen SF, Zhou ZP, Wu XY, Yang F*, Liang H. Multidrug delivery systems based on human serum albumin for combination therapy with three anticancer agents. Molecular Pharmaceutics, 2016, 13: 3098−3105.

4. Qi JX, Liang SC, Gou Y, Zhang Z, Zhou ZL, Yang F*, Liang H*. Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanism. European Journal of Medicinal Chemistry, 2015, 96: 360−368.

学习经历：

2013/09-2016/06，广西师范大学化学与药学学院(硕士)

毕业去向：

毕业后于东南大学继续读博深造，现就职于河南平顶山学院医学院，省级工程技术中心主任

邮箱：823153301@qq.com